ProVerum

Biotech & Life Sciences · Dublin, Ireland · Founded 2016

Redefining Minimally Invasive Treatment for BPH MoreLess

Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity College Dublin, developing novel treatment solutions for patients with symptomatic benign prostatic hyperplasia (BPH).

ProVerum has developed a minimally invasive implant for patients with symptomatic Benign Prostatic Hyperplasia (BPH) as an alternative to invasive surgery.

Valuation $250–500M

Revenue $1–10M

Headcount <100

Total funding $100–500M

Unlock exact values

Talent graph

ProVerum's talent

Book a demo to see the people

Team profiled 6 named & role-tagged

Founders /100 quality score

Key operators 2 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

13 investors on ProVerum's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 7 investors entered at this stage

Atlantic Bridge University Fund

EIT Health

Irrus Investments

Halo Business Angel Network

Enterprise Ireland

Boole

European Innovation Council

Series A 6 investors entered at this stage

Gilde Healthcare

Lightstone Ventures

Medtech

MVM Life Science Partners

OrbiMed

Ireland Strategic Investment Fund

Global footprint

Where ProVerum has talent and traffic

Workforce by country

3 countries with
team presence

🇮🇪 Ireland66.7%

🇺🇸 United States30.8%

🇬🇧 United Kingdom2.6%

3 countries shown

Market sentiment

What the market is saying about ProVerum

An AI-synthesized read of the highest-engagement posts about ProVerum on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ProVerum on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles